VerifiedFact Checked
Are weight loss injections and pancreatitis connected?

Are weight loss injections and pancreatitis connected?

There have been reports of acute pancreatitis in people taking weight loss injections containing GLP-1 receptor agonists – but are the two linked?

While prior evidence suggested there was no increased risk of pancreatitis when using weight loss injections, more research is currently being carried out to investigate the relationship between the two further.

Alexandra Cristina Cowell
Medically reviewed by
Alexandra Cristina Cowell, Writer & Clinical Content Reviewer
Go to
Medically reviewed by
Dr Alexandra Cristina Cowell
Writer & Clinical Content Reviewer
on Jul 02, 2025.
Meet Alexandra Cristina  
Alexandra Cristina

Last updated on Nov 07, 2025.

Was this article useful?
  • promiseThere has been a surge in cases of pancreatitis among GLP-1 receptor agonist users.
  • GLP-1 receptor agonists are prescribed to treat type-2 diabetes and obesity, both of which are associated with an increased risk of pancreatitis.
  • Current evidence leaves it unclear whether GLP-1 receptor agonists are associated with an increased risk of pancreatitis, or if it’s due to the conditions they’re used to treat.
  • If you experience pancreatic side effects while using GLP-1 receptor agonists, report them to the FDA's MedWatch program.

What are GLP-1s?

GLP-1 stands for glucagon-like peptide 1, and it’s a naturally occurring hormone your body releases after eating. Weight loss injections like Wegovy and Zepbound contain a medication called a GLP-1 receptor agonist, which acts in the same way as naturally occurring GLP-1. This provides a few different benefits:

  • It increases the amount of insulin you release after eating, which can help manage type-2 diabetes.
  • It slows down how quickly food passes through the digestive system, and targets the part of your brain responsible for regulating appetite and satiety. This helps manage cravings and hunger, which can assist with weight loss.

There’s also evidence that GLP-1 treatments can reduce the risk of cardiovascular issues.

What is pancreatitis?

Pancreatitis is when your pancreas, an organ found behind your stomach, becomes inflamed. Your pancreas is a gland that makes insulin and digestive enzymes, to help you digest food and process the glucose from it. The main symptom of pancreatitis is pain in your upper abdomen that can spread through to your back.

There are two types of pancreatitis: acute and chronic. Acute pancreatitis is when your pancreas becomes inflamed for a short period of time, and gets better with a few days of treatment; this is the kind reportedly linked to weight loss injections. Chronic pancreatitis is a long-term condition that can cause damage to your pancreas over time.

What can cause pancreatitis?

There are several possible causes of pancreatitis. Sometimes it can be the secondary effect of a different health condition, but certain types of medications may be a contributing factor too.

Gallstones

Gallstones are one of the most common causes of pancreatitis. They form in your gallbladder, a small organ below your liver that stores bile. Bile is produced by your liver, and helps to digest fats in your diet. Large amounts of cholesterol (fats) can cause an imbalance in the chemical makeup of bile, which leads to crystals forming in the bile stored in your gallbladder. These can grow over many years into solid stones.

If a gallstone moves out of your gallbladder it can block the opening to your pancreas, causing it to become inflamed. This is how gallstones cause acute pancreatitis.

Alcohol

Alcohol consumption is another common cause of pancreatitis, and can lead to pancreatitis in a couple of different ways.

  1. The digestive enzymes made by your pancreas normally don’t activate until they’re in your digestive tract. But drinking alcohol can cause them to activate early, essentially causing the pancreas to ‘digest’ itself.
  2. Alcohol can also make the fluids produced by your pancreas thicker. This can cause blockages in your pancreatic ducts, leading to inflammation.

Triglyceride levels

High triglyceride (also known as hypertriglyceridemia) levels are the next most common cause of pancreatitis after alcohol and gallstones. We don’t fully understand how high triglyceride levels cause pancreatitis. One of the leading theories is that an interaction between triglycerides and the digestive enzymes released by your pancreas can produce substances that may damage the pancreas, leading to pancreatitis.

Rapid weight loss

While rapid weight loss itself isn’t thought to increase the risk of pancreatitis, some approaches to losing weight quickly can. One of these is the ketogenic (keto) diet – which involves eating very few or no carbohydrates at all.

The reason this helps you lose weight is also the reason it increases your risk of pancreatitis: without carbohydrates to use for energy, the body enters lipolysis, where it breaks down stored fats to release energy. But this also releases free fatty acids into your bloodstream, which are converted into triglycerides by your liver. This can increase your triglyceride levels, which could lead to acute pancreatitis due to hypertriglyceridemia.

The keto diet involves eating more dietary fat and fewer carbohydrates, to switch the body’s preferred source of energy from carbs to stored fat. But because most dietary fat is in the form of triglycerides, if you unknowingly eat any carbohydrates, your body can switch back to processing carbs for energy – leaving you with elevated triglyceride levels.

While eating little-to-no carbs may increase your risk of hypertriglyceridemia – eating too many can also have a similar effect. Studies show that when you eat more than the recommended level of dietary carbohydrates (over 55% of your energy intake), the concentration of triglycerides in your blood can rise. So it’s really important to maintain a healthy balance of carbs and dietary fat (whether you’re using GLP-1 treatment or not), to minimize your risk of pancreatitis.

Medications

There’s also a chance pancreatitis could be caused by a medication you’re taking. In a 2005 US review of prescription drugs associated with pancreatitis, the following medications were each found to be linked to over 20 reported cases of acute pancreatitis:

  • Didanosine (HIV treatment)
  • Asparaginase (used in treatment of acute lymphoblastic leukemia)
  • Azathioprine (used to manage rheumatoid arthritis)
  • Valproic acid (epilepsy treatment)
  • Pentavalent antimonials (leishmaniasis treatment)
  • Pentamidine (antimicrobial used to treat pneumonia, pneumocystis, leishmaniasis, and trypanosomiasis)
  • Mercaptopurine (used in the treatment of acute lymphocytic leukemia)
  • Mesalamine (used to treat ulcerative colitis)
  • Estrogen preparations (used in HT (hormone therapy) and contraception)
  • Medications used to treat moderate to severe pain
  • Tetracyclines (antibiotics used for chlamydia and stomach issues)
  • Cytarabine (used in the treatment of acute myeloid leukemia)
  • Steroids (used in many autoimmune conditions to treat inflammation)
  • Trimethoprim/sulfmethoxazole (an antibiotic)
  • Sulfasalazine (used to treat rheumatoid arthritis, colitis, and Crohn’s)
  • Furosemide (a diuretic used to flush out water)
  • Certain non-steroidal anti-inflammatory drugs (NSAIDs)

Genetics

There’s evidence that pancreatitis can be hereditary, too. Hereditary pancreatitis tends to start with cases of acute pancreatitis in childhood, which then transitions to chronic pancreatitis in early adulthood. It’s thought that variations in the PRSS1 gene are the primary cause of acute pancreatitis, accounting for 60-85% of people with hereditary pancreatitis. But not everyone with hereditary pancreatitis will have an identifiable genetic cause, and variations in other genes that haven’t been identified yet could also be responsible.

How common is pancreatitis?

In the United States, acute pancreatitis is a common reason for hospital admission, leading to about 275,000 hospital stays each year. The incidence rate varies but is estimated to be between 5 and 80 cases per 100,000 people annually. The most common causes are gallstones and heavy alcohol use.

Does type 2 diabetes increase your risk of pancreatitis?

Observational studies have reported a link between acute pancreatitis and type-2 diabetes for a long time. A 2010 study set out to gather more data on the topic – specifically on how diabetic treatment could affect pancreatitis caused by diabetes. The study identified 85,525 individuals with diabetes and 200,000 without, and asked about cases of acute pancreatitis.

243 cases were found in the general population, and 176 in the diabetes cohort – meaning there was a 30.1% incidence rate in the general population and a 54% incidence rate in the diabetes cohort. While it was noted that the level of association between diabetes and pancreatitis fell when adjusted for other factors that could cause pancreatitis, the study concluded that type-2 diabetes may be associated with an increased risk. It was also discovered that using insulin to treat type-2 diabetes could lower this risk, but further research is still needed.

What did the GLP-1 studies say?

Initial studies when GLP-1 agonists were first approved suggested there was no increased risk of acute pancreatitis in people using semaglutide. The SUSTAIN-6 trial for semaglutide found that it was associated with acute pancreatitis at the same rate as placebo.

But recent reports of pancreas problems in patients using GLP-1 receptor agonists have prompted new research to explore the link between the two.

What do the new studies say?

Data collected by regulatory bodies like the FDA has found that there were numerous cases of acute and chronic pancreatitis in people taking GLP-1 agonists – but made it clear that these cases were infrequent and it’s uncertain whether or not the medication was the cause.

Because GLP-1 receptor agonists are used to treat obesity and diabetes, and both obesity and diabetes are associated with an increased risk of pancreatitis, it can be difficult to determine whether the drug or the condition it’s treating is the cause.

Research initiatives in the US and UK are looking to investigate the link between genetics and the risk of certain side effects. This would help prevent adverse side effects by checking whether or not you have a genetic predisposition to them before you take the medication. Regulatory officials have stated that a significant number of side effects to medications could be prevented with this kind of testing.

What should you do if you experience pancreatitis symptoms on a GLP-1?

Whether you’re using GLP-1 receptor agonists or not, if you experience abdominal pain that spreads through to your back, alongside possible nausea and vomiting – you should seek medical attention right away. It may be a symptom of pancreatitis.

But it’s important to note that abdominal discomfort, nausea, and vomiting are all common and usually harmless side effects of GLP-1 receptor agonists – especially on your injection day. It’s when these symptoms get worse (with pain spreading through to your back) that you should see a doctor.

If you have any concerns about starting weight loss injections and developing pancreatitis, speak to your healthcare provider about your previous medical history. They’ll be able to advise you on whether or not GLP-1 receptor agonists are right for you. And if not, they may be able to recommend an alternative.

If you do get any pancreatic side effects while using GLP-1 receptor agonists, you should report them through the FDA’s MedWatch program. This will help improve the safety of similar medications in the future.

Reference Popover #ref1
Reference Popover #ref2
Reference Popover #ref3
Reference Popover #ref4
Reference Popover #ref5
Reference Popover #ref6
Reference Popover #ref7
Reference Popover #ref8
Reference Popover #ref9
Reference Popover #ref10
Reference Popover #ref11
Reference Popover #ref12
Reference Popover #ref13
Reference Popover #ref14
Reference Popover #ref15
Reference Popover #ref16
Reference Popover #ref17
Reference Popover #ref18

Sourcing guidelines:

When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.

Tell us what you want to hear.

Have a subject you’d like us to cover in a future article? Let us know.

Give us the inbox treatment.

We're making healthcare more about you. Sign up to our newsletter for personalized health articles that make a difference.

Disclaimer: The information provided on this page is not a substitute for professional medical advice, diagnosis, or treatment. If you have any questions or concerns about your health, please talk to a doctor.

Suggest a health guide

Tell us your idea here.

(And leave your email too, so we can let you know if we write an article based on your suggestion.)